Zobrazeno 1 - 10
of 1 121
pro vyhledávání: '"cardiovascular adverse event"'
Autor:
Sreejan Saha, BA, Molly Ottensoser, BA, Brittany N. Weber, MD, PhD, Jeffrey S. Berger, MD, Michael S. Garshick, MD, MS
Publikováno v:
International Journal of Women's Dermatology, Vol 10, Iss 3, p e172 (2024)
Externí odkaz:
https://doaj.org/article/44005ff1c45445d0b1b822f6e456278b
Autor:
Saha S; College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, New York., Ottensoser M; Bernard M. Baruch College, New York City, New York., Weber BN; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Berger JS; Leon H. Charney Division of Cardiology, New York University Grossman School of Medicine, New York City, New York., Garshick MS; Leon H. Charney Division of Cardiology, New York University Grossman School of Medicine, New York City, New York.
Publikováno v:
International journal of women's dermatology [Int J Womens Dermatol] 2024 Aug 19; Vol. 10 (3), pp. e172. Date of Electronic Publication: 2024 Aug 19 (Print Publication: 2024).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lomesh Jibhau Khairnar, Vijay Pawar
Publikováno v:
International Journal For Multidisciplinary Research. 4
The use of Hydroxychloroquine combine with Azythromycin for the treatment of coronavirus disease (COVID-19) it may increases the risk of serious cardiovascular advere events. WHO not recommended for the use of HCQ to treat the COVID-19 because it has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d86e4ff1888b394aa25beb4de982463
https://doi.org/10.36948/ijfmr.2022.v04i06.1012
https://doi.org/10.36948/ijfmr.2022.v04i06.1012
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
Externí odkaz:
https://doaj.org/article/80cc6a0a58ca497dadf3d4c2ffb51d26
Publikováno v:
Journal of Clinical Laboratory Analysis
Background ST‐segment elevation myocardial infarction (STEMI) is a common clinical acute and severe disease, and it is of great significance to evaluate the prognosis of these patients. Hemoglobin levels are associated with a variety of diseases, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586c2ab3414b63798fb486ec42752d14
https://doi.org/10.1002/jcla.24126
https://doi.org/10.1002/jcla.24126
Publikováno v:
European Heart Journal. 42
Background Peripheral artery disease (PAD) increase the risk of comorbidity and mortality in coronary artery disease (CAD). Objectives We evaluate influence of PAD on prognosis in patients undergoing percutaneous coronary intervention (PCI). Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6127ddfb5973697dfd0e64ce9288f070
https://doi.org/10.1093/eurheartj/ehab724.1149
https://doi.org/10.1093/eurheartj/ehab724.1149
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionMultiple myeloma (MM) is a leading cause of hematopoietic cancer-related mortality, accounting for 20% of deaths. MM-targeted therapies have demonstrated efficacy, and since 2015, the United States Food and Drug Administration (FDA) has a
Externí odkaz:
https://doaj.org/article/deda3009d3994af7ae689b72db8100c2
Autor:
Piazza, Lavinia a, 1, 2, Carollo, Anna b, 1, Di Martino, Enrica b, 1, Novara, Maria Eugenia b, 1, Cutaia, Sofia c, 1, Provenzani, Alessio b, 1, Rizzo, Sergio c, ⁎, 1
Publikováno v:
In Critical Reviews in Oncology / Hematology February 2025 206